In Brief: Aleve ad agency change
This article was originally published in The Tan Sheet
Executive Summary
Aleve ad agency change: Advertising for the OTC analgesic will be handed by BBDO, Bayer AG's worldwide agency. Euro RSCG Tatham, which handles Bayer's Mycelex-7 and Midol brands, as well as One-A-Day, Flintstones and Bugs Bunny vitamins, will take on Femstat 3 three-day vaginal yeast infection treatment advertising. Bayer acquired the rights to Aleve and Femstat 3 last year through a joint venture with Roche; previously, the brands were marketed by Procter & Gamble in the U.S. ("The Tan Sheet" Sept. 23, 1996, p. 10). Aleve advertising formerly was handled by D'Arcy, Masius, Benton & Bowles and Femstat 3 by Leo Burnett...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning